Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

NCT01652794 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT01652794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leydig cell tumor, ovarian sarcoma, ovarian stromal cancer, pseudomyxoma peritonei, recurrent cervical cancer, recurrent endometrial carcinoma, recurrent fallopian tube cancer, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, recurrent primary peritoneal cavity cancer, recurrent uterine sarcoma, recurrent vaginal cancer, recurrent vulvar cancer